Drug Therapy
The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.
Subtype terms (38)
More specific conditions that are subtypes of Drug Therapy in the MeSH hierarchy.
- Antineoplastic Protocols
1 drug experimental
- Chelation Therapy
- Chemoprevention
5 drugs (2 approved, 3 experimental)
- Chemoradiotherapy
31 drugs (16 approved, 15 experimental)
- Chemotherapy, Adjuvant
31 drugs (20 approved, 11 experimental)
- Consolidation Chemotherapy
- COVID-19 Drug Treatment
- Deprescriptions
4 drugs approved
- Drug Administration Routes
- Drug Administration Schedule
5 drugs (4 approved, 1 experimental)
- Drug Delivery Systems
30 drugs (24 approved, 6 experimental)
- Drug Dosage Calculations
7 drugs (3 approved, 4 experimental)
- Drug Prescriptions
- Drug Tapering
- Drug Therapy, Combination
20 drugs (17 approved, 3 experimental)
- Drug Therapy, Computer-Assisted
- Electrochemotherapy
1 drug approved
- Enema
- Enzyme Therapy
- Fluid Therapy
20 drugs (13 approved, 7 experimental)
- Home Infusion Therapy
- Hormone Replacement Therapy
9 drugs approved
- Inappropriate Prescribing
- Induction Chemotherapy
12 drugs (9 approved, 3 experimental)
- Maintenance Chemotherapy
4 drugs experimental
- Medication Errors
- Molecular Targeted Therapy
11 drugs (6 approved, 5 experimental)
- Nicotine Replacement Therapy
- Opiate Substitution Treatment
8 drugs approved
- Orthomolecular Therapy
- Photochemotherapy
8 drugs (6 approved, 2 experimental)
- Pleurodesis
2 drugs approved
- Polypharmacy
- Premedication
13 drugs (11 approved, 2 experimental)
- Sclerotherapy
- Self Administration
- Self Medication
- Thrombolytic Therapy
3 drugs approved
Drugs by status
Phase 4 trials (30)
- metformin
- secukinumab
- oxytocin
- epoetin
- carbetocin
- esmolol
- alpha-lipoic acid
- dexlansoprazole
- butylphthalide
- finerenone
- hetrombopag olamine
- esketamine
- amoxicillin
- olanzapine
- oliceridine
- risperidone
- sitagliptin
- sarpogrelate
- cyclosporine
- acetylsalicylic acid
- sufentanil
- glucose
- Anti-thymocyte Globulin (Rabbit)
- vonoprazan
- morphine
- dapagliflozin
- sodium chloride
- esomeprazole
- nafamostat
- tegoprazan
Phase 3 trials (59)
- decitabine
- azacitidine
- anlotinib
- aztreonam
- venetoclax
- busulfan
- irinotecan
- chiglitazar
- doxorubicin
- etidronic acid
- gemcitabine
- fluorouracil
- paclitaxel
- l-glutamine
- goserelin
- palonosetron
- icosapent ethyl
- epirubicin
- Filgrastim
- leucovorin
- memantine
- beta-glucans
- Telitacicept
- immune globulin (human)
- cyclophosphamide
- temozolomide
- paliperidone
- sulodexide
- vortioxetine
- crizotinib
- +29 more
Phase 2 trials (92)
- orlistat
- phentermine
- afatinib
- atezolizumab
- urea
- darolutamide
- blinatumomab
- lenalidomide
- certolizumab pegol
- prednisone
- donafenib
- selinexor
- durvalumab
- eribulin
- enzalutamide
- fruquintinib
- obinutuzumab
- vismodegib
- ginger
- naltrexone
- granisetron
- lapatinib
- aumolertinib
- ramucirumab
- topiramate
- apalutamide
- pembrolizumab
- lenvatinib
- mangafodipir trisodium
- nimotuzumab
- +62 more
Phase 1 trials (20)